Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash & Equivalents (2020 - 2025)

Bio Essence has reported Cash & Equivalents over the past 6 years, most recently at $28741.0 for Q3 2025.

  • Quarterly results put Cash & Equivalents at $28741.0 for Q3 2025, down 3.61% from a year ago — trailing twelve months through Sep 2025 was $28741.0 (down 3.61% YoY), and the annual figure for FY2024 was $1371.0, up 1102.63%.
  • Cash & Equivalents for Q3 2025 was $28741.0 at Bio Essence, up from $1371.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for BIOE hit a ceiling of $29818.0 in Q3 2024 and a floor of $89.0 in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $572.0 (2022), compared with a mean of $7240.0.
  • Biggest five-year swings in Cash & Equivalents: tumbled 98.53% in 2022 and later surged 33403.37% in 2024.
  • Bio Essence's Cash & Equivalents stood at $303.0 in 2021, then surged by 1966.67% to $6262.0 in 2022, then crashed by 98.18% to $114.0 in 2023, then skyrocketed by 1102.63% to $1371.0 in 2024, then skyrocketed by 1996.35% to $28741.0 in 2025.
  • The last three reported values for Cash & Equivalents were $28741.0 (Q3 2025), $1371.0 (Q4 2024), and $29818.0 (Q3 2024) per Business Quant data.